Coologics

Coologics is pioneering a non-pharmaceutical, device-based intervention for vaginal yeast and bacterial infections, a large and underserved market in women's health. Its lead product, the Vlisse™ device, utilizes controlled-cooling technology to provide rapid symptom relief, aiming to address issues like antibiotic resistance, recurrent infections, and associated complications like preterm birth. The company is currently in the clinical stage, building value around a differentiated approach backed by early clinical validation and a founder with deep personal and professional insight into the condition.

Patented controlled-cooling technology delivered via a single-use medical device for the physical treatment of vaginal yeast and bacterial infections.

Coologics competes with the entrenched standard of care: OTC and prescription antifungal/antibiotic drugs. It also faces potential competition from other non-pharmaceutical approaches, such as probiotic supplements, pH-balancing products, and emerging microbiome-based therapies, though its physical cooling mechanism appears unique.